Assessment of Measurement Variability Across Automated Biometry Devices

NCT06045325 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 204

Last updated 2025-05-13

Study results available
· View outcomes & findings →

Summary

This is a non-interventional prospective, comparative study of white-to-white, corneal thickness, and anterior chamber depth measurements as taken on the Orbscan II compared to the IOL Master 700 (Zeiss), IOL Master 500 (Zeiss), Atlas 9000 (Zeiss), Lenstar 900 (Haag-Streit), Argos (Alcon), iTrace (Tracey), Pentacam (Oculus), and manual calipers.

Conditions

  • Myopia

Interventions

DIAGNOSTIC_TEST

Orbscan II

Diagnostic assessment to measure anterior chamber depth, white-to-white, and corneal thickness.

DIAGNOSTIC_TEST

IOL Master 700

Diagnostic assessment to measure anterior chamber depth, white-to-white, and corneal thickness.

DIAGNOSTIC_TEST

IOL Master 500

Diagnostic assessment to measure anterior chamber depth, white-to-white, and corneal thickness.

DIAGNOSTIC_TEST

Atlas 9000

Diagnostic assessment to measure white-to-white.

DIAGNOSTIC_TEST

Lenstar 900

Diagnostic assessment to measure anterior chamber depth, white-to-white, and corneal thickness.

DIAGNOSTIC_TEST

Pentacam

Diagnostic assessment to measure anterior chamber depth, white-to-white, and corneal thickness.

DIAGNOSTIC_TEST

iTrace

Diagnostic assessment to measure white-to-white and corneal thickness.

DIAGNOSTIC_TEST

Argos

Diagnostic assessment to measure anterior chamber depth, white-to-white, and corneal thickness.

DIAGNOSTIC_TEST

Manual caliper measurement

Manual diagnostic assessment to measure white-to-white.

Sponsors & Collaborators

  • Berkeley Eye Center

    lead OTHER

Principal Investigators

  • Morgan Micheletti, MD · Berkeley Eye Center

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-25
Primary Completion
2024-02-16
Completion
2024-02-16
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06045325 on ClinicalTrials.gov